UBS Group’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

UBS Group’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-6,599	Closed	-$34K	–	8487
2016 Q4	$34K	Sell	6,599 -1,174	-15%	-$5.52K	﹤0.01%	6154
2016 Q3	$36K	Sell	7,773 -1,958	-20%	-$9.14K	﹤0.01%	5796
2016 Q2	$39K	Buy	9,731 +2,181	+29%	+$8.15K	﹤0.01%	5730
2016 Q1	$23K	Sell	7,550 -3,688	-33%	-$12.4K	﹤0.01%	6115
2015 Q4	$51K	Sell	11,238 -17,162	-60%	-$81.4K	﹤0.01%	5807
2015 Q3	$134K	Buy	28,400 +4,112	+17%	+$26.5K	﹤0.01%	4983
2015 Q2	$173K	Buy	24,288 +17,774	+273%	+$134K	﹤0.01%	4997
2015 Q1	$55K	Sell	6,514 -13,824	-68%	-$118K	﹤0.01%	5954
2014 Q4	$189K	Buy	+20,338	New	+$177K	﹤0.01%	5107

Other funds holding DSCI

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

UBS Group's DSCI Position: Q1 2017 in Review

UBS Group sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 6,599 shares — an estimated $34K sold.

UBS Group first reported a position in DSCI in Q4 2014 and held it in 9 quarters. The position peaked at $189K in Q4 2014. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

UBS Group reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
UBS Group sold 6,599 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $34K.
UBS Group first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q4 2014 and held it in 9 quarters.
UBS Group's Derma Sciences, Inc. Common Stock (DE) position peaked at $189K in Q4 2014.
1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on UBS Group's 13F filing for Q1 2017, filed 12 May 2017.